Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 24, 2025

October 24, 2025

AI in Biotechnology Market to Reach $11.4 Billion by 2030

GlobeNewswire

October 24, 2025

Incubator Stock Review Initiates Coverage on Vystar

GlobeNewswire

October 24, 2025

Halda Therapeutics Announces First-in-Human Results for HLD-0915, an Oral RIPTAC™ Therapeutic Demonstrating Encouraging Safety and Anti-Tumor Activity in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

GlobeNewswire

October 24, 2025

Remix Therapeutics Announces Positive Preliminary Data from Phase 1 Study of REM-422 in Patients with Adenoid Cystic Carcinoma at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 24, 2025

Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety

GlobeNewswire

October 24, 2025

Evolving Treatment Landscape for Chronic Spontaneous Urticaria Highlights Significant Unmet Needs and Expanding Opportunities for Therapeutic Innovation

GlobeNewswire

October 24, 2025

Canatu grants license for commercial production of CNT pellicle membranes using CNT100 SEMI reactor

GlobeNewswire

October 24, 2025

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

GlobeNewswire

October 24, 2025

First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine

GlobeNewswire

October 24, 2025

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

GlobeNewswire

October 24, 2025

FibroBiologics to Present at Bio-Europe 2025

GlobeNewswire

October 24, 2025

rYojbaba Expands Partnership with China Zhongqing International Holdings to Implement Free Labor Union Program for Japan’s Technical Intern Training and Specified Skilled Worker Programs

GlobeNewswire

October 24, 2025

Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051

GlobeNewswire

October 24, 2025

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025

GlobeNewswire

October 24, 2025

HealthLynked Launches New MedOfficeDirect Shopify Platform at DiscountOnlineMedicalSupplies.com with Improved Performance and Lower Prices

GlobeNewswire

October 24, 2025

Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference

GlobeNewswire

October 24, 2025

23andMe Research Institute Names Brad Margus and Stephen Quake, D.Phil., to Board of Directors

GlobeNewswire

October 24, 2025

ProPhase Labs to Present at the 2025 ThinkEquity Conference

GlobeNewswire

October 24, 2025

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population

GlobeNewswire

October 24, 2025

SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio

GlobeNewswire